Sapiens (SPNS) is in advanced talks with U.S. investment funds over the sale of a controlling stake in the company in a deal valuing the company between $2B and $2.2B, Almog Azar of Calcalist reported. Sapiens is reportedly nearing the final stages of negotiations. A senior company executive told Calcalist that if the parties reach an agreement in the next two days, the transaction could push back the release of its quarterly earnings, now slated for Wednesday.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPNS:
